Mike grabs his clusters of differentiation notes,
forgetting what antiCD40 ligand is all about for a
moment...then checks the bgen stock price, eeek!
Tripled in the last year huh--and the street loves
that momentum!
This post is kind of in regards to Avonex, and anti-CD40
prospects, and includes a link to a pick of mine...shameless.
Okay Avonex...CBS Marketwatch calls Biogen a one trick pony...
cbs.marketwatch.com
but that's not fair
Ah yes...If the Anti-CD40 MAB is successful in trials
then in 5 years Biogen will have a bigger market cap than AMGEN
The big guys just get bigger...you know, I had biogen options
once, back in 1997, after they expired worthless I did not have
the sense to buy the stock outright, gosh...I suck.
But I am not going to give up! Biogen owners can stop reading
at this point, I should stick to my own thread forgodsake...
Right now there are no agents available to stimulate
myelin regeneration in humans. There are provocative research
reports on the use of progesterone to stimulate regeneration
of myelin outside the brain and spinal cord; this study was
performed in mice. Insulin-derived Growth Factor (IGF) and
Glial Growth Factor (GGF) are two molecules that appear to
promote some regrowth of myelin in the central nervous system
(brain and spinal cord). Over the next few years, we can look
forward to Phase 1 studies of these two agents in humans with demyelinating disease.
aspin.asu.edu
...and finally my query on Ricks thread regarding GGF2
(note, the first page is more cd40 stuff, medi/btrn
but page down to my trial balloon on Cambridge NeuroScience)
Message 7254663
Thank you for the chance to post and vent, I will go away now.
--Mike |
